你可能没想到，一种我们日常生活中很常见常的食物，虽然脂肪含量不低，却常常出现在各种健康饮食 推荐里，它就是——花生。 外表平平无奇的它，其实暗藏着丰富的营养和健康密码。那么，吃花生都能为我们身体带来哪些好处？ 每天吃多少合适？ 高植物优质蛋白+"好"脂肪 花生的营养真不错 花生不仅仅是一种美味的食物，更是一个营养宝库。根据《中国食物成分表（标准版）》的数据，每 100克生花生仁的营养成分如下： | 美型 | 项目 | 含量 | | --- | --- | --- | | 能量与相关成分 | 能量 | 574kcal | | | 蛋白质 | 24.8g | | | 脂肪 | 44.3g | | | 碳水化合物 | 21.7g | | 维生素 | 维生素 B1 | 0.72mg | | | 烟酸 | 17.90mg | | 矿物质 | 第 | 39mg | | | 전 | 324mg | | | 钾 | 587mg | | | 镇 | 178mg | | | 铁 | 2.1mg | | | 将 | 2.5mg | 花生蛋白含有人体所需的8种必需氨基酸，虽然其氨基酸组成与动物蛋白略有差异（例如蛋氨酸含量相 对较低） ...

皱纹、白发...... 有没有那么一瞬间 感觉自己突然"老了"？ 衰老不只是这些肉眼可见的痕迹 更是身体内部悄然发生的细微改变 最近一项研究发现 做一个小改变 饭吃七八分饱 时常让身体保持微微饥饿感 帮你抗衰老、延长寿命 01 2个年龄段是衰老关键点 2025年7月，《细胞》（Cell）期刊发表的一项研究，通过分析人体50年的蛋白质变化，绘制了清晰 的"衰老路线图"，还指出了两个关键转折期身体里发生的"剧变"。 研究发现了两个衰老的关键点： 衰老有两个关键的年龄段 "30岁左右"和"45岁至55岁" 但别急 研究者表示，限制进食时产生延缓衰老的益处与具体食物种类或营养多少无关，仅饥饿感本身就足以产 生抗衰老、延长寿命的益处。 30岁左右衰老开始 肾上腺组织率先呈现衰老特征，内分泌稳态失衡可能是早期驱动因素，同期主动脉也出现稳态偏移。 通俗来说，身体内部的"老化程序"已经默默按下了开始键，别仗着年轻就挥霍啦！ 45～55岁衰老"里程碑式转折点" 大多数器官蛋白质组在此阶段经历"分子级联风暴"，差异表达蛋白呈爆发性增长，标志其成为多器官系 统性衰老的关键生物学转变窗口。尤其是主动脉蛋白质组在此过程中变化最为剧烈。 ...

Core Viewpoint - Aimeike Technology Development Co., Ltd. reported a decline in revenue and net profit for Q1 2025, indicating challenges in the medical aesthetics industry amid increased competition and regulatory pressures [1][2]. Financial Performance - In Q1 2025, Aimeike achieved revenue of 663 million yuan, a year-on-year decrease of 17.90% - The net profit attributable to shareholders was 444 million yuan, down 15.87% year-on-year [1]. Market Trends - The non-surgical light medical aesthetics market is expected to grow at a rate of 10% in 2024, down from previous highs in 2023, as the industry transitions from "technical dividends" to "comprehensive competitiveness" [2]. - Increased competition has led to a downward trend in product prices, while consumer decision-making periods for high-end medical aesthetics have lengthened due to macroeconomic uncertainties [2]. Strategic Positioning - Aimeike is one of the few leading companies not actively participating in price wars, maintaining a gross margin of 93.85% in Q1 2025, a slight decrease of 0.7 percentage points year-on-year [4]. - The company emphasizes brand value and product quality over short-term price advantages, aiming for long-term market resilience [4]. Research and Development - Aimeike's R&D expenses reached 58.54 million yuan in Q1 2025, accounting for 8.82% of revenue, an increase of 1.65% year-on-year, reflecting a strong commitment to innovation [4]. - Ongoing projects focus on cutting-edge areas such as regenerative materials and collagen, which may not yield immediate sales but are expected to drive long-term growth [4]. Product Expansion - Aimeike has received approval for a new product, a medical-grade gel for jawline filling, which will soon be launched, marking it as the third approved product in this category in China [5]. - The company is also expanding its market presence through the acquisition of 85% of South Korea's REGEN Biotech Inc. for approximately 190 million USD, positioning itself as the only domestic company with two regenerative medical aesthetics products [5].